Literature DB >> 11435851

Significant medical pathology discovered during a male infertility evaluation.

P N Kolettis1, E S Sabanegh.   

Abstract

PURPOSE: Because a pregnancy can be achieved without a male infertility evaluation, some have questioned its usefulness. However, by bypassing a urological evaluation the man might not learn the cause of infertility and not be offered specific corrective therapy. In addition, men with subfertility may have a serious underlying medical or genetic problem that could also be overlooked. We determine the incidence of significant medical pathology discovered during a male infertility evaluation at 2 academic infertility practices.
MATERIALS AND METHODS: All men examined for either primary or secondary infertility were included in our study, while men seen for vasectomy reversal were not. All patients underwent evaluation, consisting of a complete history, physical examination, semen analysis, hormone testing, urinalysis and genetic testing when appropriate.
RESULTS: Significant medical pathology was discovered in 33 of 536 (6%) patients. A total of 27 patients had genetic abnormalities, including cystic fibrosis mutations in 24 and karyotypic abnormalities in 3. Of the remaining 6 patients 1 had testis cancer, 1 prostate cancer, 3 diabetes mellitus and 1 hypothyroidism.
CONCLUSIONS: Significant medical pathology can be detected by a male infertility evaluation. In addition to identifying the cause of infertility, the evaluation may uncover conditions that threaten the health of the male partner or any potential offspring.

Entities:  

Mesh:

Year:  2001        PMID: 11435851

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

Review 1.  Male reproductive health and prostate cancer risk.

Authors:  Thomas J Walsh
Journal:  Curr Opin Urol       Date:  2011-11       Impact factor: 2.309

2.  Proper diagnosis and management of nonobstructive azoospermia: NYU Case of the Month, June 2017.

Authors:  Joseph Alukal
Journal:  Rev Urol       Date:  2017

Review 3.  Use of Ultrasound in Male Infertility: Appropriate Selection of Men for Scrotal Ultrasound.

Authors:  Joseph M Armstrong; Sorena Keihani; James M Hotaling
Journal:  Curr Urol Rep       Date:  2018-05-28       Impact factor: 3.092

Review 4.  Urologic conditions associated with malignancy.

Authors:  Eric M Lo; James M Hotaling; Alexander W Pastuszak
Journal:  Urol Oncol       Date:  2019-01-02       Impact factor: 3.498

Review 5.  Contemporary concepts in the evaluation and management of male infertility.

Authors:  Kathleen Hwang; R Chanc Walters; Larry I Lipshultz
Journal:  Nat Rev Urol       Date:  2011-01-18       Impact factor: 14.432

Review 6.  Thyroid disease and male reproductive function.

Authors:  G E Krassas; P Perros
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

7.  Severe oligozoospermia in a patient with myxedema coma.

Authors:  Akira Komiya; Akihiko Watanabe; Yoko Kawauchi; Atsuko Takano; Hideki Fuse
Journal:  Reprod Med Biol       Date:  2012-05-09

Review 8.  Male infertility: a risk factor for testicular cancer.

Authors:  James M Hotaling; Thomas J Walsh
Journal:  Nat Rev Urol       Date:  2009-09-01       Impact factor: 14.432

9.  Surgical or radiological treatment for varicoceles in subfertile men.

Authors:  Emma Persad; Clare Aa O'Loughlin; Simi Kaur; Gernot Wagner; Nina Matyas; Melanie Rosalia Hassler-Di Fratta; Barbara Nussbaumer-Streit
Journal:  Cochrane Database Syst Rev       Date:  2021-04-23

10.  Underutilization of primary medical care among men presenting for fertility evaluation.

Authors:  Joshua A Halpern; Annie L Darves-Bornoz; Richard J Fantus; Mary Kate Keeter; James Wren; Nelson E Bennett; Robert E Brannigan
Journal:  F S Rep       Date:  2020-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.